Abstract
Increased circulating alpha-1-antitrypsin (AAT) correlates with cancer stage/aggressiveness, but its role in cancer biology is unclear. We revealed antagonistic effect of AAT to cisplatin-induced cytotoxicity in prostate (PC3) and melanoma (A375) cancer cell lines. Moreover, AAT abrogated cytotoxicity of MEK inhibitor U0126 in PC3 cell line. Weaker antagonistic effect of AAT on cytotoxicity of PI3/Akt and NF-kB inhibitors was also observed. In addition, cisplatin increased AAT gene expression in transfected PC3 cells. However, AAT derived from transfected PC3 cells did not antagonize cisplatin-induced cytotoxicity. In conclusion, these results suggest possible association between high circulating AAT and cisplatin resistance.
Similar content being viewed by others
References
Crystal RG (1989) The alpha 1-antitrypsin gene and its deficiency states. Trends Genet 5:411–417
Blank CA, Brantly M (1994) Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency. Ann Allergy 72:105–120
Mason DY, Cramer EM, Massé JM, Crystal R, Bassot JM, Breton-Gorius J (1991) Alpha 1-antitrypsin is present within the primary granules of human polymorphonuclear leukocytes. Am J Pathol 139:623–628
Molmenti EP, Perlmutter DH, Rubin DC (1993) Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J Clin Invest 92:2022–2034
Perlmutter DH, Daniels JD, Auerbach HS, De Schryver-Kecskemeti K, Winter HS, Alpers DH (1989) The alpha 1-antitrypsin gene is expressed in a human intestinal epithelial cell line. J Biol Chem 264:9485–9490
Sallenave JM, Tremblay GM, Gauldie J, Richards CD (1997) Oncostatin M, but not interleukin-6 or leukemia inhibitory factor, stimulates expression of alpha1-proteinase inhibitor in A549 human alveolar epithelial cells. J Interf Cytokine Res 17:337–346
Cichy J, Potempa J, Travis J (1997) Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells. J Biol Chem 272:8250–8255
Ikari Y, Mulvihill E, Schwartz SM (2001) Alpha 1-Proteinase inhibitor, alpha 1-antichymotrypsin, and alpha 2-macroglobulin are the antiapoptotic factors of vascular smooth muscle cells. J Biol Chem 276:11798–11803
Daemen MA, Heemskerk VH, van’t Veer C, Denecker G, TG W, Vandenabeele P, WA B (2000) Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation 102:1420–1426
Petrache I, Fijalkowska I, Zhen L, Medler TR, Brown E, Cruz P, Choe KH, Taraseviciene-Stewart L, Scerbavicius R, Shapiro L, Zhang B, Song S, Hicklin D, Voelkel NF, Flotte T, Tuder RM (2006) A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med 173:1222–1228
Greene CM, Miller SD, Carroll TP, Oglesby IK, Ahmed F, O’Mahony M, Taggart CC, McElvaney NG, O’Neill SJ (2010) Anti-apoptotic effects of Z alpha1-antitrypsin in human bronchial epithelial cells. Eur Respir J 35:1155–1163
Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, Petrache HI, Flotte TR, Tuder RM (2006) Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 169:1155–1166
Lockett AD, Van Demark M, Gu Y, Schweitzer KS, Sigua N, Kamocki K, Fijalkowska I, Garrison J, Fisher AJ, Serban K, Wise RA, Flotte TR, Mueller C, RG P Jr, Petrache HI, Tuder RM, Petrache I (2012) Effect of cigarette smoke exposure and structural modifications on the α-1 antitrypsin interaction with caspases. Mol Med 18:445–454
Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R (1992) An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis. Br J Cancer 65:300–302
Kwon CH, Park HJ, Lee JR, Kim HK, Jeon TY, Jo HJ, Kim DH, Kim GH, Park DY (2014) Serpin peptidase inhibitor clade a member 1 is a biomarker of poor prognosis in gastric cancer. Br J Cancer 111:1993–2002
Chang YH, Lee SH, Liao IC, Huang SH, Cheng HC, Liao PC (2012) Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells. Mol Cell Proteomics 11:1320–1339
Kataoka H, Uchino H, Iwamura T, Seiki M, Nabeshima K, Koono M (1999) Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. Am J Pathol 154:457–468
Zelvyte I, Lindgren S, Janciauskiene S (2003) Multiple effects of alpha1-antitrypsin on breast carcinoma MDA-MB 468 cell growth and invasiveness. Eur J Cancer Prev 12:117–124
Zhao W, Yang Z, Liu X, Tian Q, Lv Y, Liang Y, Li C, Gao X, Chen L (2013) Identification of α1-antitrypsin as a potential prognostic biomarker for advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors by proteomic analysis. J Int Med Res 41:573–583
Topic A, Ljujic M, Petrovic-Stanojevic N, Dopudja-Pantic V, Radojkovic D (2011) Phenotypes and serum level of alpha-1-antitrypsin in lung cancer. J BUON 16:672–676
Varela AS, López Sáez JJ (1995) Utility of plasmatic levels of alpha-1-antiprotease (A1AP) as a cancer marker. Cancer Lett 89:15–21
Pérez-Holanda S, Blanco I, Menéndez M, Rodrigo L (2014) Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls. BMC Cancer 14:355
Mijatovic S, Maksimovic-Ivanic D, Radovic J, Popadic D, Momcilovic M, Harhaji L, Miljkovic D, Trajkovic V (2004) Aloe-emodin prevents cytokine-induced tumor cell death: the inhibition of auto-toxic nitric oxide release as a potential mechanism. Cell Mol Life Sci 61:1805–1815
McCubrey JA, Steelman LS, Abrams SL, Misaghian N, Chappell WH, Basecke J, Nicoletti F, Libra M, Ligresti G, Stivala F, Maksimovic-Ivanic D, Mijatovic S, Montalto G, Cervello M, Laidler P, Bonati A, Evangelisti C, Cocco L, Martelli AM (2012) Targeting the cancer initiating cell: the ultimate target for cancer therapy. Curr Pharm Des 18:1784–1795
EMBL-EBI Expression Atlas, available on: http://www.ebi.ac.uk/gxa/experiments.
Kubisch R, Meissner L, Krebs S, Blum H, Günther M, Roidl A, Wagner EA (2013) Comprehensive gene expression analysis of resistance formation upon metronomic cyclophosphamide therapy. Transl Oncol 6:1–9
El-Akawi ZJ, Abu-Awad AM, Sharara AM, Khader Y (2010) The importance of alpha-1 antitrypsin (alpha1-AT) and neopterin serum levels in the evaluation of non-small cell lung and prostate cancer patients. Neuroendocrinol Lett 31:113–116
Zelvyte I, Wallmark A, Piitulainen E, Westin U, Janciauskiene S (2004) Increased plasma levels of serine proteinase inhibitors in lung cancer patients. Anticancer Res 24:241–247
Li Y, Krowka MJ, Qi Y, Katzmann JA, Song Y, Mandrekar SJ, Yang P (2011) Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival. J Thorac Oncol 6:291–295
Normandin K, Péant B, Le Page C, de Ladurantaye M, Ouellet V, Tonin PN, Provencher DM, Mes-Masson AM (2010) Protease inhibitor SERPINA1 expression in epithelial ovarian cancer. Clin Exp Metastasis 27:55–69
Zelvyte I, Ohlsson B, Axelson J, Janciauskiene S (2003) Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment. Anticancer Res 23(3B):2267–2273
Zelvyte I, Sjögren HO, Janciauskiene S (2002) Effects of native and cleaved forms of alpha1-antitrypsin on ME 1477 tumor cell functional activity. Cancer Detect Prev 26:256–265
Boulikas T, Vougiouka M (2003) Cisplatin and platinum drugs at the molecular level. Oncol Rep 10:1663–1682
Fuertes MA, Castilla J, Alonso C, Pérez JM (2003) Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem 10:257–266
Ljujic M, Mijatovic S, Bulatovic MZ, Mojic M, Maksimovic-Ivanic D, Radojkovic D, Topic A (2016) Alpha-1 antitrypsin affects U0126-induced cytotoxicity in colon cancer cell line (HCT116. Mol Biol 50:153–156
Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122:927–939
Marquez RT, Xu L (2012) Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res 2:214–221
Wei Y, Pattingre S, Sinha S, Bassik M, Levine B (2008) JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell 30:678–688
Chekhun VF, Kovtonyuk OV, Todor IN, Kulik GI (2005) Total proteolytic activity and levels of the main proteinase inhibitors in blood plasma of mice bearing Lewis lung carcinoma upon development of resistance to cisplatin. Exp Oncol 27:286–289
Dabbagh K, Laurent GJ, Shock A, Leoni P, Papakrivopoulou J, Chambers RC (2001) Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J Cell Physiol 186:73–81
Gonias SL, Swaim MW, Massey MF, Pizzo SV (1988) cis-dichlorodiammineplatinum (II) as a selective modifier of the oxidation-sensitive reactive-center methionine in alpha 1-antitrypsin. J Biol Chem 263:393–397
Kloth JN, Gorter A, Fleuren GJ, Oosting J, Uljee S, ter Haar N, Dreef EJ, Kenter GG, Jordanova ES (2008) Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma. J Pathol 215:222–230
Kwon CH, Park HJ, Choi JH, Lee JR, Kim HK, Jo HJ, Kim HS, Oh N, Song GA, do Y P (2015) Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancer. Oncotarget 6:20312–20326
JY W, Cheng CC, Wang JY, DC W, Hsieh JS, Lee SC, Wang WM (2014) Discovery of tumor markers for gastric cancer by proteomics. PLoS One 9:e84158
Goodarzi MT, Turner GA (1995) Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian cancer. Clin Chim Acta 236:161–171
Comunale MA, Rodemich-Betesh L, Hafner J, Wang M, Norton P, Di Bisceglie AM, Block T, Mehta A (2010) Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma. PLoS One 5:e12419
Wang Y, Kuramitsu Y, Yoshino S, Takashima M, Zhang X, Ueno T, Suzuki N, Oka M, Nakamura K (2011) Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry. Oncol Rep 26:287–292
Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883–899
Huang W, Ding X, Li B, Fan M, Zhou T, Sun H, Yi Y, Zhang J (2013) Serum biomarkers analyzed by LC-MS/MS as predictors for short outcome of non-small cell lung cancer patients treated with chemoradiotherapy. Neoplasma 60:11–18
Woźniak B, Mila-Kierzenkowska C, WoŸniak A, Drewa G, Sopońska M, Drewa T, Krzyzyńska-Malinowska E, Makarewicz R, Kowalski T, Szmytkowska K (2008) The effect of combined therapy on activity of cathepsin D and alpha-1-antitrypsin in the blood serum of women with cervical cancer. Eur J Gynaecol Oncol 29:617–619
Acknowledgments
This work was supported by the Serbian Ministry of Education and Science (Grants No 173013 and 173008). Authors wish to thank Dr. Djordje Miljkovic from Institute for Biological Research “Sinisa Stankovic”, University of Belgrade for help in performing flow cytometry and Dr. Stanislava Stosic Grujicic from Institute for Biological Research “Sinisa Stankovic”, University of Belgrade for insightful comments and critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors have declared no conflicts of interest.
Rights and permissions
About this article
Cite this article
Ljujic, M., Mijatovic, S., Bulatovic, M.Z. et al. Alpha-1-Antitrypsin Antagonizes Cisplatin-Induced Cytotoxicity in Prostate Cancer (PC3) and Melanoma Cancer (A375) Cell Lines. Pathol. Oncol. Res. 23, 335–343 (2017). https://doi.org/10.1007/s12253-016-0104-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-016-0104-3